Patients also showed increased FAT10 expression which correlate with CXCL9 and CXCL10, supporting solid crosstalk between FAT10 and these proinflammatory cytokines in NASH pathophysiology (Dali-Youcef et al., 2019). Here, CXCL10 is linked to metabolic dysfunction-associated steatohepatitis.